Gritstone Oncology Inc (NASDAQ:GRTS)
| 8.65 Delayed Data As of 2:04pm ET |  -0.58 / -6.29%Today’s Change | 7.00 Today|||52-Week Range 15.94 | -3.58% Year-to-Date |
Latest GRTS News | Press Releases
No recent news for Gritstone Oncology Inc.
Today’s Trading
| Previous close | 9.23 |
| Today’s open | 9.29 |
| Day’s range | 8.60 - 9.64 |
| Volume | 67,262 |
| Average volume (3 months) | 155,612 |
| Market cap | $374.2M |
Data as of 2:04pm ET, 02/25/2020
Growth & Valuation
| Earnings growth (last year) | -423.53% |
| Earnings growth (this year) | +63.40% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 0.8 |
| Price/Sales | 116.09 |
| Price/Book | 2.02 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTMXCytomX Therapeutics ... | -0.21 | -2.90% |
| OSMTOsmotica Pharmaceuti... | -0.37 | -6.62% |
| STMLStemline Therapeutic... | -0.28 | -4.21% |
| TCRRTCR2 Therapeutics In... | -0.49 | -3.61% |
Data as of 2:23pm ET, 02/25/2020
Financials
| Last reporting date | February 17, 2020 |
| EPS forecast (this quarter) | -$0.72 |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$64.8M |
| Net profit margin | -5,457.03% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
